Loading...

Gap Junction Enhancer Increases Efficacy of Cisplatin to Attenuate Mammary Tumor Growth

Cisplatin treatment has an overall 19% response rate in animal models with malignant tumors. Increasing gap junction activity in tumor cells provides the targets to enhance antineoplastic therapies. Previously, a new class of substituted quinolines (PQs) acts as gap junction enhancer, ability to inc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Shishido, Stephanie N., Nguyen, Thu A.
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3441663/
https://ncbi.nlm.nih.gov/pubmed/23028705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0044963
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!